Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyper IgD Syndrome”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableEnded earlyNCT00260299
What this trial is testing

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Who this might be right for
Mevalonic AciduriaMevalonate Kinase DeficiencyImmune System Diseases+2 more
Oregon Health and Science University 1
Testing effectiveness (Phase 2)Study completedNCT01303380
What this trial is testing

Canakinumab in Patients With Active Hyper-IgD Syndrome

Who this might be right for
Mevalonate Kinase Deficiency
Novartis Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT02911857
What this trial is testing

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Who this might be right for
Periodic Fevers Syndrome
Novartis Pharmaceuticals 4
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Not applicableWithdrawnNCT01568736
What this trial is testing

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency

Who this might be right for
Hyper IgD SyndromeMevalonate Kinase Deficiency
Michigan Technological University
Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31